Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD19 (clone S2E). We employs the HBV (T7-RFP-IL-10-BamHI) vector components and the SynExpress system of the Introns Substitution/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD19
Clone
S2E
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
IL-10
Insertion Sites
BamHI
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.92
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.